C-Kit (CD117) Expression in Patients with Small Cell Lung Cancer
Aim: The tyrosine-kinase receptor c-kit and its ligand stem cell factor (SCF) are coexpressed in many small cell lung cancer (SCLC) cell lines. The aim of this study was to search the role of CD117 (c-kit) overexpression as a prognostic marker in SCLC. Methods: Demographic and clinical data of p...
Main Authors: | Ayşe Gözkaman, Özkan Kanat, Meral Günaldı, Özlem Saraydaroğlu, A. Baki Kumbasar |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2015-03-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: | http://www.hasekidergisi.com/article_8702/C-kit-cd117-Expression-In-Patients-With-Small-Cell-Lung-Cancer |
Similar Items
-
Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer
by: Kwang-Hyeok Kim, et al.
Published: (2022-02-01) -
Small cell carcinoma of the urinary bladder: KIT and PDGFRA gene mutations
by: Nuket Eliyakin, et al.
Published: (2015-12-01) -
CD117 (c-Kit) Is Expressed During CD8+ T Cell Priming and Stratifies Sensitivity to Apoptosis According to Strength of TCR Engagement
by: Guido Frumento, et al.
Published: (2019-03-01) -
Identification of candidate genes for lung cancer somatic mutation test kits
by: Yong Chen, et al.
Published: (2013-01-01) -
Evaluation of c-Kit (CD117) expression in patients with squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) of the skin
by: Mazaher Ramezani, et al.
Published: (2021-02-01)